Nine Energy Service Announces Timing of Second Quarter 2025 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--Nine Energy Service, Inc. (NYSE: NINE) announced today that it has scheduled its second quarter 2025 earnings conference call for Wednesday, August 6, 2025, at 9:00 am Central Time. During the call, Nine will discuss its financial and operating results for the quarter ended June 30, 2025, which are expected to be released prior to the conference call.
Participants may join the live conference call by dialing U.S. (Toll Free): (877) 524-8416 or International: (412) 902-1028 and ask for the 'Nine Energy Service Earnings Call.' Participants are encouraged to dial into the conference call ten to fifteen minutes before the scheduled start time to avoid any delays entering the earnings call.
For those who cannot listen to the live call, a telephonic replay of the call will be available through August 20, 2025, and may be accessed by dialing U.S. (Toll Free): (877) 660-6853 or International: (201) 612-7415 and enter passcode 13754403.
About Nine Energy Service
Nine Energy Service is an oilfield services company that offers completion solutions within North America and abroad. The Company brings years of experience with a deep commitment to serving clients with smarter, customized solutions and world-class resources that drive efficiencies. Serving the global oil and gas industry, Nine continues to differentiate itself through superior service quality, wellsite execution and cutting-edge technology. Nine is headquartered in Houston, Texas with operating facilities in the Permian, Eagle Ford, Haynesville, SCOOP/STACK, Niobrara, Barnett, Bakken, Marcellus, Utica and Canada.
For more information on the Company, please visit Nine's website at nineenergyservice.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Why NextEra Energy Is a Top Dividend Stock to Watch in 2025
NextEra Energy, Inc. (NYSE:NEE) is one of the Best Stocks to Buy for Dividends. A wind turbine, its blades spinning to generate clean renewable energy. The company benefits from a strong two-part business model. Its regulated utility arm, Florida Power & Light, delivers steady cash flow, while its renewable energy segment, NextEra Energy Resources, supports future growth through clean energy development. NextEra Energy, Inc. (NYSE:NEE) has increased its dividend for 29 straight years and currently offers a solid 3.22% yield. For income-focused investors, the company provides both the reliability of a utility and strong potential for dividend growth. Its yield stands out compared to many clean energy stocks, and a five-year dividend growth rate of 10.5% reflects management's commitment to rewarding shareholders. With a payout ratio of 59.7%, the company maintains a healthy balance between reinvesting in growth and sustaining dividends. Looking ahead, management expects earnings to grow between 6% and 8% annually through at least 2027, supporting continued dividend increases. NextEra Energy, Inc. (NYSE:NEE) currently offers a quarterly dividend of $0.5665 per share. While we acknowledge the potential of NEE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
What Makes Medtronic a Leader in Medical Devices
Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in. A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy. The company remains a major player in the medical technology space as it focuses on medical devices. Its broad product lineup targets a variety of chronic conditions, including heart disease, diabetes, chronic pain, and acute care needs. With strengths across several therapeutic areas, the company has multiple paths for growth and holds a strong position in each market it serves. R&D is key in healthcare, often drawing attention to smaller companies with breakthrough potential, but they carry high risk and usually don't pay dividends. Medtronic plc (NYSE:MDT) stands out as a stable, mature firm that offers a dividend. The company has raised its payouts for 48 consecutive years, which means that it's just two years away from becoming a Dividend King. The company pays a quarterly dividend of $0.71 per share and has a dividend yield of 3.30%, as of June 24. Medtronic plc (NYSE:MDT) recently announced that it will spin off its diabetes care division into an independent, publicly traded company within the next 18 months. The move is part of its strategy to streamline operations and focus on core, high-margin growth areas. Although it will part with its fastest-growing segment, Medtronic plc (NYSE:MDT)'s overall business remains strong, with a broad portfolio of products that continue to deliver steady revenue and profits. In a tough market, investors often favor reliable, stable companies like Medtronic. While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Why JNJ Is a Long-Term Winner
Johnson & Johnson (NYSE:JNJ) is one of the Best Wide Moat Dividend Stocks to Invest in. A smiling baby with an array of baby care products in the foreground. Johnson & Johnson (NYSE:JNJ) is a long-established leader in the healthcare industry, with a strong portfolio of high-performing drugs in areas like immunology and cancer treatment, along with a thriving medical devices business. In 2023, the company separated its slower-growing consumer health segment, which includes well-known products such as Band-Aids and Tylenol, by launching it as an independent publicly listed firm called Kenvue (KVUE). In times of economic uncertainty, large and reputable healthcare companies like Johnson & Johnson (NYSE:JNJ) are often considered reliable investment options. The company currently offers a dividend yield of 3.4%. While the dividend remains steady and continues to grow, the stock price itself can vary significantly from year to year. The company holds one of the longest dividend growth streaks in the market, spanning 63 years. It offers a quarterly dividend of $1.30 per share. In March, Johnson & Johnson (NYSE:JNJ) announced plans to increase its investment in US operations, committing more than $55 billion over the next four years to develop new manufacturing and research facilities. This represents a 25% increase compared to its investment over the previous four years. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
